Weighted Average Number of Shares Outstanding, Basic of RenovoRx, Inc. from 31 Mar 2021 to 30 Sep 2025

Taxonomy & unit: us-gaap: shares
Description: Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary: RenovoRx, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Mar 2021 to 30 Sep 2025.
RenovoRx, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 36,646,278, a 47% increase year-over-year.
RenovoRx, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 22,271,163, a 116% increase from 2023.
RenovoRx, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 10,290,667, a 14% increase from 2022.
RenovoRx, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 9,051,726, a 74% increase from 2021.
Source SEC data: View on sec.gov

Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)

Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)

Weighted Average Number of Shares Outstanding, Basic, Annual (shares)

Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

RenovoRx, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	36,646,278	+11,705,532	+47%	01 Jul 2025	30 Sep 2025	10-Q	13 Nov 2025	2025	Q3
Q2 2025	36,576,567	+12,527,454	+52%	01 Apr 2025	30 Jun 2025	10-Q	14 Aug 2025	2025	Q2
Q1 2025	31,395,888	+16,448,388	+110%	01 Jan 2025	31 Mar 2025	10-Q	15 May 2025	2025	Q1
Q4 2024	22,271,163	+11,980,496	+116%	01 Oct 2024	31 Dec 2024	10-K	01 Apr 2025	2024	FY
Q3 2024	24,940,746	+14,247,666	+133%	01 Jul 2024	30 Sep 2024	10-Q	13 Nov 2025	2025	Q3
Q2 2024	24,049,113	+13,393,958	+126%	01 Apr 2024	30 Jun 2024	10-Q	14 Aug 2025	2025	Q2
Q1 2024	14,947,500	+5,857,511	+64%	01 Jan 2024	31 Mar 2024	10-Q	15 May 2025	2025	Q1
Q4 2023	10,290,667	+1,238,941	+14%	01 Oct 2023	31 Dec 2023	10-K	01 Apr 2025	2024	FY
Q3 2023	10,693,080	+1,625,571	+18%	01 Jul 2023	30 Sep 2023	10-Q	13 Nov 2024	2024	Q3
Q2 2023	10,655,155	+1,597,970	+18%	01 Apr 2023	30 Jun 2023	10-Q	13 Aug 2024	2024	Q2
Q1 2023	9,089,989	+97,585	+1.1%	01 Jan 2023	31 Mar 2023	10-Q	10 May 2024	2024	Q1
Q4 2022	9,051,726	+3,834,726	+74%	01 Oct 2022	31 Dec 2022	10-K	01 Apr 2024	2023	FY
Q3 2022	9,067,509	+3,447,374	+61%	01 Jul 2022	30 Sep 2022	10-Q	13 Nov 2023	2023	Q3
Q2 2022	9,057,185	+6,772,207	+296%	01 Apr 2022	30 Jun 2022	10-Q	16 Aug 2023	2023	Q2
Q1 2022	8,992,404	+6,750,655	+301%	01 Jan 2022	31 Mar 2022	10-Q	12 May 2023	2023	Q1
Q4 2021	5,217,000			01 Oct 2021	31 Dec 2021	10-K	31 Mar 2023	2022	FY
Q3 2021	5,620,135			01 Jul 2021	30 Sep 2021	10-Q	14 Nov 2022	2022	Q3
Q2 2021	2,284,978			01 Apr 2021	30 Jun 2021	10-Q	12 Aug 2022	2022	Q2
Q1 2021	2,241,749			01 Jan 2021	31 Mar 2021	10-Q	13 May 2022	2022	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	22,271,163	+11,980,496	+116%	01 Jan 2024	31 Dec 2024	10-K	01 Apr 2025	2024	FY
2023	10,290,667	+1,238,941	+14%	01 Jan 2023	31 Dec 2023	10-K	01 Apr 2025	2024	FY
2022	9,051,726	+3,834,726	+74%	01 Jan 2022	31 Dec 2022	10-K	01 Apr 2024	2023	FY
2021	5,217,000			01 Jan 2021	31 Dec 2021	10-K	31 Mar 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.